FDA NDC Directory · JSON-LD · Markdown

ERMEZA

NDC 49502-378 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic namelevothyroxine sodium
Labeler / ManufacturerViatris Specialty LLC
Marketing categoryNew Drug Application (innovator) · App NDA215809
Dosage form / routeSOLUTION · ORAL
Active ingredientsLEVOTHYROXINE SODIUM (30 ug/mL)
Marketing started20221214
Marketing ended20260731
Package count2

External sources

Source: openFDA. Public-domain (CC0).